CAW
GSK icon

Cornerstone Advisors (Washington)’s GSK GSK Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,763
Closed -$88K – 1065
2019
Q2 		$88K Buy
1,763
+414
+31% +$20.8K 0.01% 277
2019
Q1 		$70K Buy
1,349
+773
+134% +$38.6K 0.01% 285
2018
Q4 		$28K Buy
576
+17
+3% +$837 0.01% 435
2018
Q3 		$28K Buy
559
+162
+41% +$8.23K 0.02% 463
2018
Q2 		$20K Buy
397
+205
+107% +$10.3K 0.01% 505
2018
Q1 		$9K Buy
+192
New +$8.94K 0.01% 606
2017
Q4 		– Sell
-126
Closed -$6K – 919
2017
Q3 		$6K Sell
126
-110
-47% -$5.58K ﹤0.01% 668
2017
Q2 		$13K Buy
236
+159
+206% +$8.48K 0.01% 547
2017
Q1 		$4K Hold
77
– – ﹤0.01% 715
2016
Q4 		$4K Sell
77
-40
-34% -$1.98K ﹤0.01% 729
2016
Q3 		$6K Hold
117
– – 0.01% 657
2016
Q2 		$6K Hold
117
– – 0.01% 523
2016
Q1 		$6K Sell
117
-177
-60% -$8.82K 0.01% 528
2015
Q4 		$15K Buy
294
+280
+2,000% +$14.3K 0.02% 366
2015
Q3 		$1K Sell
14
-86
-86% -$4.48K ﹤0.01% 806
2015
Q2 		$5K Hold
100
– – ﹤0.01% 407
2015
Q1 		$6K Buy
100
+14
+16% +$803 ﹤0.01% 412
2014
Q4 		$5K Buy
+86
New +$4.81K ﹤0.01% 390
2014
Q2 		– Sell
-250
Closed -$17K – 671
2014
Q1 		$17K Sell
250
-246
-50% -$16.6K 0.02% 147
2013
Q4 		$33K Hold
496
– – 0.05% 81
2013
Q3 		$31K Sell
496
-54
-10% -$3.48K 0.05% 80
2013
Q2 		$34K Buy
+550
New +$34.9K 0.08% 36

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Cornerstone Advisors (Washington)'s GSK Position: Q3 2019 in Review

Cornerstone Advisors (Washington) sold out of GSK (GSK) in Q3 2019, closing a stake of 1,763 shares — an estimated $88K sold.

Cornerstone Advisors (Washington) first reported a position in GSK in Q2 2013 and held it in 22 quarters. The position peaked at $88K in Q2 2019. 805 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

  • Cornerstone Advisors (Washington) reported no remaining GSK position as of Q3 2019 after selling out during the quarter.
  • Cornerstone Advisors (Washington) sold 1,763 GSK shares in Q3 2019, an estimated $88K.
  • Cornerstone Advisors (Washington) first reported a position in GSK in Q2 2013 and held it in 22 quarters.
  • Cornerstone Advisors (Washington)'s GSK position peaked at $88K in Q2 2019.
  • 805 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2019, filed 23 Oct 2019.